Figure 2From: Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA) Prevalence of lipid abnormalities before and after treatment with lipid modifying therapy in high-risk patients (n = 2,016).Back to article page